Cargando…
Rapid Detection of HLA-B*57:01-Expressing Cells Using a Label-Free Interdigitated Electrode Biosensor Platform for Prevention of Abacavir Hypersensitivity in HIV Treatment
Pre-treatment screening of individuals for human leukocyte antigens (HLA) HLA-B*57:01 is recommended for the prevention of life-threatening hypersensitivity reactions to abacavir, a drug widely prescribed for HIV treatment. However, the implementation of screening in clinical practice is hindered by...
Autores principales: | Chan, Jianxiong, Soraya, Gita V., Craig, Lauren, Uddin, Shah M., Todaro, Marian, Huynh, Duc H., Abeyrathne, Chathurika D., Kostenko, Lyudmila, McCluskey, James, Skafidas, Efstratios, Kwan, Patrick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6719006/ https://www.ncbi.nlm.nih.gov/pubmed/31416185 http://dx.doi.org/10.3390/s19163543 |
Ejemplares similares
-
Ultrasensitive and label-free biosensor for the detection of Plasmodium falciparum histidine-rich protein II in saliva
por: Soraya, Gita V., et al.
Publicado: (2019) -
Development of an Ultrasensitive Impedimetric Immunosensor Platform for Detection of Plasmodium Lactate Dehydrogenase
por: Low, Yu Kong, et al.
Publicado: (2019) -
A Label-Free, Quantitative Fecal Hemoglobin Detection Platform for Colorectal Cancer Screening
por: Soraya, Gita V., et al.
Publicado: (2017) -
Comparison of Methods for In-House Screening of HLA-B*57:01 to Prevent Abacavir Hypersensitivity in HIV-1 Care
por: De Spiegelaere, Ward, et al.
Publicado: (2015) -
An ab-initio Computational Method to Determine Dielectric Properties of Biological Materials
por: Abeyrathne, Chathurika D., et al.
Publicado: (2013)